Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China

Tropical Medicine and International Health

Volumn 14, Issue 10, 2009, Pages 1266-1271

  Zhang, G Q ^a   Guan, Y Y ^a   Zheng, B ^a   Wu, S ^a   Tang, L H ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Drug resistance; Plasmodium falciparum; Polymerase chain reaction; Single nucleotide polymorphism

Indexed keywords

CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN CHLOROQUINE RESISTANCE TRANSPORTER; UNCLASSIFIED DRUG;

DRUG RESISTANCE; MOLECULAR ANALYSIS; POLYMERASE CHAIN REACTION; PROTOZOAN;

ADULT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHINA; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMALARIALS; CHINA; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA;

PLASMODIUM FALCIPARUM;

EID: 70349249658     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02342.x     Document Type: Article

References (31)

1. Cowman AF, Morry MJ, Biggs BA, Cross GA Foote SJ (1988) Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 85, 9109 9113.
2. Djimde A, Doumbo OK, Cortese JF et al. (2001) A molecular marker for chloroquine-resistant falciparum malaria. The New England Journal of Medicine 344, 257 263.
3. Djimde AA, Dolo A, Ouattara A, Diakite S, Plowe CV Doumbo OK (2004) Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. The Journal of Infectious Diseases 190, 853 855.
4. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M Warhurst DC (2000) The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Molecular and Biochemical Parasitology 108, 13 23.
5. Foote SJ, Galatis D Cowman AF (1990) Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the United States of America 87, 3014 3017.
6. Gregson A Plowe CV (2005) Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews 57, 117 145.
7. Guan YY, Tang LH, Hu L, Feng XP Liu DQ (2005) The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium alciparum isolated from Hainan Province. Chinese Journal of Parasitology & Parasitic Diseases 23, 135 139.
8. Happi CT, Gbotosho GO, Folarin OA et al. (2005) Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Tropicana 95, 183 193.
9. Johnson DJ, Fidock DA, Mungthin M et al. (2004) Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Molecular Cell 15, 867 877.
10. Kublin JG, Dzinjalamala FK, Kamwendo DD et al. (2002) Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases 185, 380 388.
11. Lakshmanan V, Bray PG, Verdier-Pinard D et al. (2005) A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO Journal 24, 2294 2305.
12. Liu DQ, Liu RJ, Ren DX et al. (1992) Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Chinese Journal of Parasitology & Parasitic Diseases 10, 241 244.
13. Liu DQ, Liu RJ, Ren DX et al. (1995) Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bulletin of the World Health Organization 73, 483 486.
14. Liu DQ, Feng XP, Yang HL, Lin SG, Chen WJ Yang PF (2005) Fluctuation in the resistance of Plasmodium falciparum to chloroquine in China. Chinese Journal of Parasitology & Parasitic Diseases 23, 27 31.
15. Ndiaye D, Daily JP, Sarr O et al. (2005) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Tropical Medicine and International Health 10, 1176 1179.
16. Nguyen-Dinh P Trager W (1978) Chloroquine resistance produced in vitro in an African strain of human malaria. Science 200, 1397 1398.
17. Pearce RJ, Drakeley C, Chandramohan D, Mosha F Roper C (2003) Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrobial Agents and Chemotherapy 47, 1347 1354.
18. Peterson DS, Walliker D Wellems TE (1988) Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America 85, 9114 9118.
19. Plowe CV (2003) Monitoring antimalarial drug resistance: making the most of the tools at hand. The Journal of Experimental Biology 206, 3745 3752.
20. Robert V, Molez JF Trape JF (1996) Short report: gametocytes chloroquine pressure and the relative parasite survival advantage of resistant strains of falciparum malaria in west Africa. American Journal of Tropical Medicine and Hygiene 55, 350 351.
21. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y Santi DV (1997) Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America 94, 1124 1129.
22. Tang LH (2000) Progress in malaria control in China. Chinese Medical Journal (Engl) 113, 89 92.
23. Triglia T, Menting JG, Wilson C Cowman AF (1997) Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 94, 13944 13949.
24. Wernsdorfer WH, Landgraf B, Wiedermann G Kollaritsch H (1995) Chloroquine resistance of Plasmodium falciparum: a biological advantage? Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 90 91.
25. Wooden J, Kyes S Sibley CH (1993) PCR and strain identification in Plasmodium falciparum. Parasitology Today 9, 303 305.
26. Woodrow CJ Krishna S (2006) Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance. Cellular and Molecular Life Sciences 63, 1586 1596.
27. World Health Organization (2005) Susceptibility of Plasmodium falciparum to antimalarial drugs: Report on global monitoring 1996-2004. WHO, Geneva.
28. Yang H, Liu D, Dong Y et al. (1995) Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border. Chinese Journal of Parasitology & Parasitic Diseases 13, 111 113.
29. Yang H, Liu D, Huang K et al. (1999) Assay of sensitivity of Plasmodium falciparum to chloroquine amodiaquine piperaquine mefloquine and quinine in Yunnan province. Chinese Journal of Parasitology & Parasitic Diseases 17, 43 45.
30. Yang Z, Zhang Z, Sun X et al. (2007) Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Tropical Medicine and International Health 12, 1051 1060.
31. Zhou SS, Wang Y Tang LH (2007) Malaria situation in the People' s Republic of China in 2006. Chinese Journal of Parasitology & Parasitic Diseases 25, 439 441.